De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Alkermes Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Alkermes heeft een totaal eigen vermogen van $1.3B en een totale schuld van $289.5M, wat de schuld-eigenvermogensverhouding op 22.5% brengt. De totale activa en totale passiva bedragen respectievelijk $2.2B en $922.8M. De EBIT Alkermes is $303.0M waardoor de rentedekking -19.9 is. Het heeft contanten en kortetermijnbeleggingen van $876.1M.
Belangrijke informatie
22.5%
Verhouding schuld/eigen vermogen
US$289.46m
Schuld
| Rente dekkingsratio | -19.9x |
| Contant | US$876.12m |
| Aandelen | US$1.28b |
| Totaal verplichtingen | US$922.84m |
| Totaal activa | US$2.21b |
Recente financiële gezondheidsupdates
Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?
Aug 29Recent updates
Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17Alkermes: Fairly Valued After Post-Earnings Bump
Jul 28Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?
Jul 26Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry
Jul 04The Bottom Fishing Club: Alkermes Has Great Value And Safety
May 17Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals
May 08Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data
Apr 09Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
Jan 26Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding
Jun 07Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?
Apr 10Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20Alkermes upgraded to neutral at BofA on improved risk/reward outlook
Oct 14Alkermes holder Sarissa Capital says it may look to increase its stake
Oct 07Alkermes: Nothing Stands Out As Interesting
Sep 26Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?
Aug 29Alkermes initiated at neutral at Piper Sandler as company in transition
Aug 16Alkermes Q2 2022 Earnings Preview
Jul 26Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?
Jun 27Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?
May 16Alkermes: Turning The Tides Towards Profitability
Apr 16Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.5B ) ALKS } overtreffen de korte termijn passiva ( $515.5M ).
Langlopende schulden: De kortetermijnactiva ALKS ( $1.5B ) overtreffen de langetermijnschulden ( $407.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ALKS heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van ALKS is de afgelopen 5 jaar gedaald van 25.5% naar 22.5%.
Schuldendekking: De schuld van ALKS wordt goed gedekt door de operationele kasstroom ( 129.2% ).
Rentedekking: ALKS verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.